Amneal Pharmaceuticals, Inc Class A Common Stock Financials

Values in thousands	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Revenue	$796,197	$722,519	$814,319	$784,513
Gross Profit	334,508	320,113	297,190	273,974
EBITDA	193,780	186,061	160,699	111,664
EBIT	145,980	142,870	111,472	57,591
Net Income	57,662	62,256	35,076	2,369
Net Change In Cash	796,197	722,519	814,319	784,513
Free Cash Flow	-64,854	-42,585	87,146	103,400
Cash	127,637	197,656	310,871	201,249
Basic Shares	328,102	328,933	324,805	324,754

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$3,018,760	$2,793,957	$2,393,607	$2,212,304
Gross Profit	1,136,092	1,020,438	863,869	791,461
EBITDA	603,872	439,773	500,782	440,208
EBIT	380,300	203,582	271,382	200,033
Net Income	72,057	-116,886	-83,993	-129,985
Net Change In Cash	3,018,760	2,793,957	2,393,607	2,212,304
Cost of Revenue				-215,829
Free Cash Flow	269,929	220,109	276,388	-25,495
Cash	310,871	110,552	91,542	25,976
Basic Shares	324,805	308,978	176,136	150,944